Aster DM Healthcare Ltd. (IN:ASTERDM)
:ASTERDM
Want to see IN:ASTERDM full AI Analyst Report?
Top Page
Aster DM Healthcare Ltd.
(ASTERDM)
Select Model
Select Model
Rating:63Neutral
Price Target:
₹746.00
▲(21.26% Upside)
Action:ReiteratedDate:05/02/26
The score is driven primarily by improving (but still uneven) financial performance, supported by positive technical momentum. These are meaningfully offset by a demanding valuation (very high P/E and low dividend yield).
Positive Factors
Improving leverage and balance-sheet strength
Debt-to-equity falling to ~0.49 reflects materially reduced leverage versus prior years, strengthening financial flexibility. Lower leverage lessens interest burden and gives management scope to fund capex, clinics or selective M&A without immediate reliance on new external financing.
Negative Factors
Earnings volatility and one-off spikes
Marked volatility, including an unusual FY2025 profit spike, reduces confidence in earnings sustainability. For investors and managers, this makes forecasting, budgeting and capital-allocation decisions harder and increases the risk that reported profits may not persist across cycles.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving leverage and balance-sheet strength
Debt-to-equity falling to ~0.49 reflects materially reduced leverage versus prior years, strengthening financial flexibility. Lower leverage lessens interest burden and gives management scope to fund capex, clinics or selective M&A without immediate reliance on new external financing.
Read all positive factors
Aster DM Healthcare Ltd. (ASTERDM) vs. iShares MSCI India ETF (INDA)
Market Cap
₹385.84B
Dividend Yield0.84%
Average Volume (3M)57.99K
Price to Earnings (P/E)61.6
Beta (1Y)0.37
Revenue Growth12.20%
EPS Growth-93.03%
CountryIN
Employees14,016
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)N/A
Shares Outstanding518,121,030
10 Day Avg. Volume86,592
30 Day Avg. Volume57,995
Financial Highlights & Ratios
PEG Ratio-0.96
Price to Book (P/B)7.55
Price to Sales (P/S)7.44
P/FCF Ratio171.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Aster DM Healthcare Ltd. Business Overview & Revenue Model
Company Description
Aster DM Healthcare Limited operates as a healthcare company in India and internationally. The company operates through Hospitals, Clinics, Retail Pharmacies, and Other segments. It provides primary, secondary, tertiary, and quaternary healthcare ...
How the Company Makes Money
Aster DM Healthcare primarily earns revenue by delivering healthcare services through its owned/operated facilities. The largest revenue driver is typically patient care at hospitals, which includes (1) inpatient services such as room/bed charges,...
Aster DM Healthcare Ltd. Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
67
Positive
Cash Flow
55
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 42.56B | 46.43B | 40.69B | 36.38B | 29.52B | 102.53B |
| Gross Profit | 27.24B | 14.23B | 31.31B | 27.22B | 21.68B | 73.62B |
| EBITDA | 8.74B | 9.01B | 8.27B | 5.87B | 4.73B | 15.34B |
| Net Income | 3.31B | 3.88B | 53.78B | 1.29B | 4.25B | 5.26B |
Balance Sheet | ||||||
| Total Assets | 78.08B | 81.12B | 66.06B | 179.91B | 148.81B | 125.46B |
| Cash, Cash Equivalents and Short-Term Investments | 12.76B | 13.27B | 13.81B | 1.11B | 3.96B | 3.69B |
| Total Debt | 20.89B | 22.20B | 20.18B | 13.84B | 57.00B | 49.07B |
| Total Liabilities | 30.37B | 32.78B | 29.55B | 129.61B | 100.21B | 80.64B |
| Stockholders Equity | 45.33B | 45.76B | 34.28B | 45.60B | 44.48B | 39.53B |
Cash Flow | ||||||
| Free Cash Flow | 873.00M | 2.01B | 790.10M | -6.39B | 9.86B | 7.65B |
| Operating Cash Flow | 3.19B | 6.71B | 4.25B | 1.58B | 18.34B | 13.13B |
| Investing Cash Flow | -747.80M | -4.36B | 60.15B | -8.85B | -9.72B | -5.70B |
| Financing Cash Flow | -2.14B | -1.72B | -63.58B | 10.53B | -8.17B | -6.85B |
Aster DM Healthcare Ltd. Technical Analysis
Positive
615.20
Price Trends
638.91
Positive
626.53
Positive
630.69
Positive
Market Momentum
10.33
Negative
58.59
Neutral
77.97
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ASTERDM, the sentiment is Positive. The current price of 615.2 is below the 20-day moving average (MA) of 662.03, below the 50-day MA of 638.91, and below the 200-day MA of 630.69, indicating a bullish trend. The MACD of 10.33 indicates Negative momentum. The RSI at 58.59 is Neutral, neither overbought nor oversold. The STOCH value of 77.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:ASTERDM.
Aster DM Healthcare Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ₹362.83B | 31.59 | ― | 1.04% | 14.78% | 13.41% | |
71 Outperform | ₹366.23B | 75.82 | ― | 0.24% | 25.81% | -0.76% | |
65 Neutral | ₹273.07B | 114.01 | ― | ― | 26.29% | -13.63% | |
65 Neutral | ₹314.83B | 83.79 | ― | 0.04% | 17.16% | 1.24% | |
63 Neutral | ₹385.84B | 61.58 | ― | 0.84% | 12.20% | -93.03% | |
61 Neutral | ₹299.41B | 27.13 | ― | 1.07% | 6.70% | 20.25% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
IN:ASTERDM
Aster DM Healthcare Ltd.
742.85
224.31
43.26%
IN:AJANTPHARM
Ajanta Pharma Limited
2,900.90
429.80
17.39%
IN:GLAND
Gland Pharma Ltd.
1,773.10
371.95
26.55%
IN:KIMS
Krishna Institute of Medical Sciences Limited
675.95
12.70
1.91%
IN:MEDANTA
Global Health Limited
1,170.60
-15.77
-1.33%
IN:NH
Narayana Hrudayalaya Ltd.
1,762.55
-28.68
-1.60%
Aster DM Healthcare Ltd. Corporate Events
Aster DM Healthcare posts FY26 earnings call recording for investors
May 1, 2026
Aster DM Healthcare Ltd. has announced that the video and audio recording of its earnings call for the quarter and year ended March 31, 2026, held on May 1, 2026, is now available on the company’s website. The disclosure, made to both BSE an...
Aster DM Healthcare Seeks Shareholder Nod via E-Voting on Director Appointment and Loan Powers
Mar 13, 2026
Aster DM Healthcare has initiated a postal ballot process to seek shareholder approval for key corporate actions, including the appointment of Dr. Mandayapurath Azad Moopen as an Executive Director and authorization to grant loans, guarantees, or ...
Aster DM Wins Strong Vote for QCIL Merger, Set to Form Top-Three Hospital Chain
Mar 11, 2026
Aster DM Healthcare has secured strong stakeholder backing for its planned amalgamation with Quality Care India Ltd., winning 96.68% shareholder approval, including a significant majority of minority shareholders, as well as support from unsecured...
Aster DM Healthcare Shareholders Clear Amalgamation with Quality Care India
Mar 11, 2026
Aster DM Healthcare Ltd. operates hospitals and other medical facilities, offering a range of healthcare services to patients in India and beyond, and its shares are listed on both BSE and NSE, giving it access to a wide base of public investors. ...
Aster DM Healthcare’s creditors clear key vote on amalgamation plan
Mar 11, 2026
Aster DM Healthcare said its unsecured trade creditors have approved a proposed Scheme of Amalgamation between Quality Care India Ltd. and Aster DM Healthcare Ltd., as directed by the National Company Law Tribunal, Hyderabad Bench. The resolution ...
Aster DM Healthcare Releases Latest Investor Presentation on Company Performance
Feb 5, 2026
Aster DM Healthcare Ltd. has released an investor presentation detailing the company’s recent performance to the stock exchanges in Mumbai. The disclosure signals ongoing engagement with shareholders and the broader market, providing investo...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.